As of this week in Montana, any biotech company with an experimental drug has a clear path to selling it to consumers. Companies whose drugs have been through preliminary testing—sometimes in as few as 10 healthy people—can pay $12,500 to apply to a newly established review board for approval. Once its treatment is rubber-stamped, the…
A new feature seemingly revealed many right-wing “America First” accounts are actually based outside the United States. But the data seems questionable.
Major insurers including AIG, Great American, and WR Berkley are asking U.S. regulators for permission to exclude AI-related liabilities from corporate policies. One underwriter describes the AI models’ outputs to the FT as “too much of a black box.”
A wave of lawsuits against OpenAI detail how ChatGPT used manipulative language to isolate users from loved ones and make itself into their sole confidant.
Waymo continues to expand its reach, with the robotaxi company posting Friday that it’s now “officially authorized to drive fully autonomously across more of the Golden State.”